Kruse et al., Kruse et al., OR Smoking status N =227574 N 207,471 1.3 1.1 1.4 0.042 2013 2013 Documentation SE= Chen et al., OR Quality of 19,193 32,365 1.16 1.11 1.22 0.015 Chen et al., 2010 diabetes care 2010 SE= QOF Coleman et OR Brief advise to No N 3.03 2.89 3.09 0.028 al., 2007 smokers SE= QOF Calvert et OR HbA1c levels of N=147 1.05 1.01 1.09 0.011 al., 2009 ≤7.5% SE= QOF Simpson et OR Smoking status Total N= 525 4.45 4.43 4.46 0.0042 0.004 al., 2010 reporting R=0.75 Smoking 6.75 6.66 6.85 0.0262 0.026 cessation advise Smoking 7.32 6.92 7.73 0.013 0.114 cessation referral Quit rates 0.73 0.72 0.73 -.075 0.0012 0.001 0.115 r= 0.75 0.013 Bardach et al, Bardach et OR Aspirin therapy, N=42 N=42 1.28 1.50 0.003 0.056 2014 al, 2014 with R=0.75 Fagan et al., IVD or DM 2010 Blood pressure 1.23 1.05 1.44 0.003 0.055 control No IVD or DM Blood pressure 0.71 0.4 1.24 -0.82 0.014 0.118 control
Kruse et al., 2013 Kruse et al., 2013 OR Smoking status Documentation N =227574 N 207,471 1.3 1.1 1.4 SE= 0.042 Chen et al., 2010 Chen et al., 2010 OR Quality of diabetes care 19,193 32,365 1.16 1.11 1.22 SE= 0.015 QOF Coleman et al., 2007 OR Brief advise to smokers No N 3.03 2.89 3.09 SE= 0.028 QOF Calvert et al., 2009 OR HbA1c levels of ≤7.5% N=147 1.05 1.01 1.09 SE= 0.011 QOF Simpson et al., 2010 OR Smoking status reporting Total N= 525 R=0.75 4.45 4.43 4.46 0.0042 0.004 Smoking cessation advise 6.75 6.66 6.85 0.0262 0.026 Smoking cessation referral 7.32 6.92 7.73 0.013 0.114 Quit rates 0.73 0.72 0.73 -.075 0.0012 r= 0.75 0.013 0.001 0.115 Bardach et al, 2014 Fagan et al., 2010 Bardach et al, 2014 OR Aspirin therapy, with IVD or DM N=42 R=0.75 N=42 1.28 1.50 0.003 0.056 Blood pressure control No IVD or DM 1.23 1.05 1.44 0.003 0.055 Blood pressure control 0.71 0.4 1.24 -0.82 0.014 0.118
Supplementary_files.docx